Figures
In Table 1, the COL6A2 mutation in Patient 14 is listed incorrectly. The mutation should be: c.1043_1051delCTGGAAACC, (p.Pro348_Asn350del). Please see the corrected Table 1 here.
In Table 2, the LAMA2 mutation in Patient 20 is listed incorrectly. The mutation should be: c.2451-6 A>G. Please see the corrected Table 2 here.
The LAMA2 mutation in Patient 20 is also listed incorrectly in the fourth sentence of the second paragraph of the MDCMD subsection of the Results section. The correct sentence is: Three frameshift deletions or insertions (c.624 delC, c.2049_2050delAG, c.2945insG), four splice site variants (c.2209-3_2209-2delCA, c.2451-6A>G, c.4311G>A, c.8989-12 C>G), and one nonsense mutation (c.1303C>T, p.Arg435) were expected to produce truncated proteins.
Reference
- 1. Liang W-C, Tian X, Yuo C-Y, Chen W-Z, Kan T-M, Su Y-N, et al. (2017) Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan. PLoS ONE 12(2): e0170517. https://doi.org/10.1371/journal.pone.0170517 pmid:28182637
Citation: Liang W-C, Tian X, Yuo C-Y, Chen W-Z, Kan T-M, Su Y-N, et al. (2017) Correction: Comprehensive target capture/next-generation sequencing as a second-tier diagnostic approach for congenital muscular dystrophy in Taiwan. PLoS ONE 12(8): e0183406. https://doi.org/10.1371/journal.pone.0183406
Published: August 10, 2017
Copyright: © 2017 Liang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.